This has led to many different biotech R&D projects that strive both to further human understanding of viral infections at the molecular level and develop novel ways to detect and treat these infections.
In the aftermath of the global COVID-19 pandemic, there has been an urgent need to invest in new ways to diagnose and treat infectious diseases. This has led to many different biotech R&D projects that strive both to further human understanding of viral infections at the molecular level and develop novel ways to detect and treat these infections.